Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.6 - $1.01 $74,877 - $126,043
-124,796 Reduced 33.94%
242,900 $245,000
Q3 2022

Nov 14, 2022

BUY
$1.22 - $2.48 $72,286 - $146,942
59,251 Added 19.21%
367,696 $460,000
Q2 2022

Aug 15, 2022

SELL
$1.63 - $3.46 $149,234 - $316,780
-91,555 Reduced 22.89%
308,445 $728,000
Q1 2022

May 16, 2022

BUY
$2.66 - $6.49 $50,449 - $123,089
18,966 Added 4.98%
400,000 $1.24 Million
Q4 2021

Feb 14, 2022

BUY
$6.24 - $10.2 $280,800 - $458,999
45,000 Added 13.39%
381,034 $2.42 Million
Q3 2021

Nov 15, 2021

SELL
$9.73 - $15.52 $35,679 - $56,911
-3,667 Reduced 1.08%
336,034 $3.35 Million
Q2 2021

Aug 16, 2021

BUY
$12.44 - $19.45 $930,387 - $1.45 Million
74,790 Added 28.23%
339,701 $4.5 Million
Q1 2021

May 14, 2021

SELL
$16.24 - $29.83 $578,842 - $1.06 Million
-35,643 Reduced 11.86%
264,911 $4.63 Million
Q4 2020

Feb 16, 2021

BUY
$14.28 - $29.73 $2.12 Million - $4.41 Million
148,229 Added 97.31%
300,554 $7.69 Million
Q3 2020

Nov 16, 2020

BUY
$12.39 - $26.15 $95,811 - $202,217
7,733 Added 5.35%
152,325 $2 Million
Q2 2020

Aug 14, 2020

SELL
$14.59 - $36.07 $513,626 - $1.27 Million
-35,204 Reduced 19.58%
144,592 $3.95 Million
Q1 2020

May 15, 2020

BUY
$8.86 - $22.2 $1.59 Million - $3.99 Million
179,796 New
179,796 $2.83 Million

Others Institutions Holding PASG

About Passage BIO, Inc.


  • Ticker PASG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,463,200
  • Market Cap $32.1M
  • Description
  • Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...
More about PASG
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.